Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Konstantinos Zarogoulidis

Showing results (1-10 of 191) with videos related to

Pageof 20
Sort By:
Expert Review of Respiratory Medicine|October 28, 2016
Diagnosing and treating pancoast tumorsKonstantinos Zarogoulidis, Konstantinos Porpodis, Kelly Domvri, et al.
Cellular Signalling|April 29, 2015
MiR-205 and miR-218 expression is associated with carboplatin chemoresistance and regulation of apoptosis via Mcl-1 and Survivin in lung cancer cellsPaul Zarogoulidis, Savvas Petanidis, Efrosini Kioseoglou, et al.
Therapeutic Advances in Medical Oncology|April 18, 2018
Tumour necrosis factor, interferon-gamma and interleukins as predictive markers of antiprogrammed cell-death protein-1 treatment in advanced non-small cell lung cancer: a pragmatic approach in clinical practiceEfimia Boutsikou, Kalliopi Domvri, Georgia Hardavella, et al.
Cancer Investigation|March 28, 2014
Interleukin-8 and interleukin-17 for cancerPaul Zarogoulidis, Fotini Katsikogianni, Theodora Tsiouda, et al.
Drug Design, Development and Therapy|May 11, 2013
Successful management of an inadvertent excessive treprostinil overdoseWolfgang Hohenforst-Schmidt, Juergen Hornig, Norbert Friedel, et al.
Translational Lung Cancer Research|March 26, 2015
Targeted versus chrono-targeted chemotherapy for inhaled chemotherapy in non-small cell lung cancerPaul Zarogoulidis, Kaid Darwiche, George Kalamaras, et al.
Anticancer Research|June 1, 2018
Epidemiological Characteristics, <i>EGFR</i> Status and Management Patterns of Advanced Non-small Cell Lung Cancer Patients: The Greek REASON Observational Registry StudyKonstantinos N Syrigos, Vasilis Georgoulias, Konstantinos Zarogoulidis, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|October 1, 2016
Comparison of diagnostic validity of mannitol and methacholine challenges and relationship to clinical status and airway inflammation in steroid-naïve asthmatic patientsKonstantinos Porpodis, Kalliopi Domvri, Theodoros Kontakiotis, et al.
Journal of Molecular and Genetic Medicine : an International Journal of Biomedical Research|January 24, 2014
Learning from the Cardiologists and Developing Eluting Stents Targeting the Mtor Pathway for Pulmonary Application; A Future Concept for Tracheal StenosisPaul Zarogoulidis, Kaid Darwiche, Kosmas Tsakiridis, et al.
Journal of Chemotherapy (Florence, Italy)|July 5, 2012
The effect of combination IFN-alpha-2a with usual antituberculosis chemotherapy in non-responding tuberculosis and diabetes mellitus: a case report and review of the literaturePaul Zarogoulidis, Ioannis Kioumis, Nikolaos Papanas, et al.
Pageof 20

Showing results (1-10 of 191) with videos related to

Sort By:
Pageof 20
Expert Review of Respiratory Medicine|October 28, 2016
Diagnosing and treating pancoast tumorsKonstantinos Zarogoulidis, Konstantinos Porpodis, Kelly Domvri, et al.
Cellular Signalling|April 29, 2015
MiR-205 and miR-218 expression is associated with carboplatin chemoresistance and regulation of apoptosis via Mcl-1 and Survivin in lung cancer cellsPaul Zarogoulidis, Savvas Petanidis, Efrosini Kioseoglou, et al.
Therapeutic Advances in Medical Oncology|April 18, 2018
Tumour necrosis factor, interferon-gamma and interleukins as predictive markers of antiprogrammed cell-death protein-1 treatment in advanced non-small cell lung cancer: a pragmatic approach in clinical practiceEfimia Boutsikou, Kalliopi Domvri, Georgia Hardavella, et al.
Cancer Investigation|March 28, 2014
Interleukin-8 and interleukin-17 for cancerPaul Zarogoulidis, Fotini Katsikogianni, Theodora Tsiouda, et al.
Drug Design, Development and Therapy|May 11, 2013
Successful management of an inadvertent excessive treprostinil overdoseWolfgang Hohenforst-Schmidt, Juergen Hornig, Norbert Friedel, et al.
Translational Lung Cancer Research|March 26, 2015
Targeted versus chrono-targeted chemotherapy for inhaled chemotherapy in non-small cell lung cancerPaul Zarogoulidis, Kaid Darwiche, George Kalamaras, et al.
Anticancer Research|June 1, 2018
Epidemiological Characteristics, <i>EGFR</i> Status and Management Patterns of Advanced Non-small Cell Lung Cancer Patients: The Greek REASON Observational Registry StudyKonstantinos N Syrigos, Vasilis Georgoulias, Konstantinos Zarogoulidis, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|October 1, 2016
Comparison of diagnostic validity of mannitol and methacholine challenges and relationship to clinical status and airway inflammation in steroid-naïve asthmatic patientsKonstantinos Porpodis, Kalliopi Domvri, Theodoros Kontakiotis, et al.
Journal of Molecular and Genetic Medicine : an International Journal of Biomedical Research|January 24, 2014
Learning from the Cardiologists and Developing Eluting Stents Targeting the Mtor Pathway for Pulmonary Application; A Future Concept for Tracheal StenosisPaul Zarogoulidis, Kaid Darwiche, Kosmas Tsakiridis, et al.
Journal of Chemotherapy (Florence, Italy)|July 5, 2012
The effect of combination IFN-alpha-2a with usual antituberculosis chemotherapy in non-responding tuberculosis and diabetes mellitus: a case report and review of the literaturePaul Zarogoulidis, Ioannis Kioumis, Nikolaos Papanas, et al.
Pageof 20